(19)
(11) EP 3 169 683 A1

(12)

(43) Date of publication:
24.05.2017 Bulletin 2017/21

(21) Application number: 15822783.5

(22) Date of filing: 16.07.2015
(51) International Patent Classification (IPC): 
C07D 403/14(2006.01)
A61K 31/496(2006.01)
A61P 35/00(2006.01)
C07D 405/14(2006.01)
A61P 19/00(2006.01)
(86) International application number:
PCT/AU2015/050400
(87) International publication number:
WO 2016/008011 (21.01.2016 Gazette 2016/03)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA

(30) Priority: 16.07.2014 US 201462025207 P

(71) Applicant: Novogen Ltd.
Hornsby, New South Wales 2077 (AU)

(72) Inventors:
  • HEATON, Andrew
    Hornsby New South Wales 2077 (AU)
  • EIFFE, Eleanor
    Hornsby New South Wales 2077 (AU)
  • POTTABATHINI, Narender
    Hyderabad 500 076 (IN)
  • GUNNING, Peter
    Sydney, New South Wales 2052 (AU)

(74) Representative: Gerli, Paolo 
Botti & Ferrari S.r.l. Via Cappellini, 11
20124 Milano
20124 Milano (IT)

   


(54) FUNCTIONALISED AND SUBSTITUTED INDOLES AS ANTI-CANCER AGENTS